Condition
Overweight and Obese Adults
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 20 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
20 shownA Single and Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP6590 in Participants With Normal Weight, Overweight and ObesityNCT07721597 · 2026-07-09
RECRUITINGEffects of Obesity on Autophagy and mTORC1 Signalling in Skeletal MuscleNCT07774676 · 2026-04-15
RECRUITINGPlant-Based Online Weight Loss Through Education and Resources Program and StudyNCT07095543 · 2026-01-02
RECRUITINGEatit's Obesity Intervention: Effects on Weight, Eating Habits and HealthNCT07183228 · 2025-09-03
RECRUITINGSex Hormones as Regulators of the Age- and Sex-dependent Benefits of Caloric RestrictionNCT07065643 · 2025-07-09
RECRUITINGAcute Effects of Isoenergetic HIIE vs. MICE on Key Parameters of Fat Mass Loss in Young Females With Overweight or ObesityNCT06868862 · 2025-02-01
RECRUITINGScreening for Malnutrition in Obese PatientsNCT06626360 · 2024-10-02
RECRUITINGStudy of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB)NCT06599918 · 2024-04-23
RECRUITINGA 12-week Field Trial of the Movámonos Physical Activity Support ProgramNCT07561996 · 2026-05-15
NOT_YET_RECRUITINGRWS of of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients.NCT07301437 · 2026-05-01
NOT_YET_RECRUITINGExercise Methods for Overweight and Obese IndividualsNCT07811596 · 2026-03-01
ACTIVE_NOT_RECRUITINGA Study of SYNT-101 to Test Safety, Tolerability and Pharmacodynamics of SYNT-101 in Healthy and Overweight AdultsNCT07307274 · 2026-01-13
COMPLETEDBehavioral Weight Loss and Sleep Health InterventionNCT07255287 · 2025-12-10
ACTIVE_NOT_RECRUITINGCHRONO-NUTRITION APPLICATION: THE EFFECT OF FIBER JELLY ON POST PRANDIAL BLOOD GLUCOSE, SATIETY AND WEIGHT LOSS AMONG OVERWEIGHT WOMENNCT07371949 · 2025-06-30
COMPLETEDEffect of Vegetables on Weight Status of University PopulationNCT06757556 · 2025-02-17
NOT_YET_RECRUITINGEffects of D-Chiro-Inositol Combined with Metformin on Insulin Resistance in People with Overweight or Obesity and T2DMNCT06860841 · 2025-01-10
ACTIVE_NOT_RECRUITINGPsychophysiological and Cognitive Responses to Low-Volume High-Intensity Interval Exercise in Overweight-to-Obese AdultsNCT07276308 · 2023-03-01
COMPLETEDRole of Leucine on Muscle Preservation During Weight Loss in Older MenNCT07781410 · 2022-11-14
COMPLETEDAssociation Analysis of Aerobic Capacity and Expiratory Forced Vital Capacity in Overweight and Obese Adults After Submaximal Exercise Training of Three WeeksNCT05145088 · 2020-09-30
UNKNOWNDose Response of Leucine on Muscle Maintenance During Weight LossNCT07583875 · 2020-08-18
COMPLETEDCommon interventions
LeucineDIETARY_SUPPLEMENT2PlaceboDRUG2BWL+SleepBEHAVIORAL1D-Chiro-Inositol Combined with MetforminDRUG1Dual-Energy X-ray Absorptiometry (DEXA) ScanRADIATION1ExerciseOTHER1Fiber jellyCOMBINATION_PRODUCT1High-Intensity Interval Training (HIIT)OTHER1Lifestyle Intervention for ObesityBEHAVIORAL1liraglutide combined with orlistatDRUG1liraglutide monotherapyDRUG1Low-fat, vegan dietBEHAVIORAL1Low-Volume High-Intensity Interval Exercise (Lv-HIIE)BEHAVIORAL1Maximal Strength TestingOTHER1Movámonos Physical Activity Support ProgramBEHAVIORAL1NicotinamideDRUG1Non-starchy vegetables will be provided to the participants as an intervention.OTHER1Phase 1 - Maintenance DietOTHER1Phase 2 - Weight loss dietOTHER1PlaceboDIETARY_SUPPLEMENT1Placebo in combination with metforminDRUG1Placebo, solution for injectionDRUG1ProteinDIETARY_SUPPLEMENT1Protein-Rich BeverageDIETARY_SUPPLEMENT1Single-leg resistance exerciseOTHER1
Leading sponsors
Nanyang Technological University
2
University of Colorado, Denver
2
Campus Bio-Medico University
1
Eatit AB
1
Foundation University Islamabad
1
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
1
HAN University of Applied Sciences
1
Istanbul Medipol University Hospital
1
Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques
1
Physicians Committee for Responsible Medicine
1
Surabaya State University
1
Syntis Bio
1
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
1
Universiti Sains Malaysia
1
University of Aberdeen
1
Trial status mix
RECRUITING8
COMPLETED5
ACTIVE_NOT_RECRUITING3
NOT_YET_RECRUITING3
UNKNOWN1
Phase mix
NA13
PHASE42
EARLY_PHASE11
PHASE11
PHASE21
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.